Research Note — Review of Corrections-Based Therapy for Opiate-Dependent Patients: Implications for Buprenorphine Treatment among Correctional Populations
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Inmates with a history of opiate dependence represent a substantial proportion of the correctional population in the United States. Opiate use has negative consequences for both the inmate and society, including increased recidivism rates, increased infectious disease prevalence, avoidable emergency room use, decreased access to primary care services, and overdose. While there have been great successes in community-based treatment of opiate dependence, these successes have not yet been achieved in correctional settings. This paper reviews the pharmacological treatment options for opiate-dependent inmates, along with potential application for community-to-correctional approaches. The recent approval by the Food and Drug Administration (FDA) of physician-prescribed buprenorphine and the new opportunities it presents to corrections-based treatment are also explored in depth. Successful implementation of such strategies is likely to result in desirable health and social outcomes for both the inmate and the community at large.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recidivism of Prisoners Released in 1994
Langan, P. A., & Levin, D. J. (2002) · Federal Sentencing Reporter · doi:10.1525/fsr.2002.15.1.58 · Cited by 1,008
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623 · cited 1×
“Several randomized, controlled trials have demonstrated BUP’s efficacy in managing opiate withdrawal (Gowing, Ali, & White, 2002; Mattick, Kimber, Breen, & Davoli, 2002) and opiate dependence (Doran et al., 2003; Johnson et al., 2000).”
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Hammett, T. M., Harmon, M. P., & Rhodes, W. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.11.1789 · Cited by 492
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175 · cited 1×
“Recently, phase II clinical trials have been begun to evaluate a longer-acting naltrexone formulation that confers effects to the subjects for up to one month (Comer et al., 2002; Modesto-Lowe, 2002); this may expand naltrexone’s applicability in both community and correctional settings.”
A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependence
Barnett, P. G., Rodgers, J. H., & Bloch, D. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9656834.x · Cited by 150
Office-Based Treatment of Opioid-Dependent Patients
Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148 · cited 3×
“As a partial agonist, there is a plateau of its agonist effects at higher doses that enhances its safety profile compared to full agonists and reduces its likelihood for street diversion (Fiellin & O’Connor, 2002; Ling & Smith, 2002).”
Cited by
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504
Self-citationSpringer, S. A., Pesanti, E., Hodges, J., Macura, T., Doros, G., & Altice, F. L. (2004) · Clinical Infectious Diseases · doi:10.1086/421392 · Cited by 260
Self-citationA randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease
Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.03.002 · Cited by 235
Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O’Grady, K. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.002238.x · Cited by 176
Metadata
- Authors
- Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L.
- Venue
- Journal of Drug Issues
- Publisher
- SAGE Publications
- Published
- 2004-04
- Volume
- 34
- Issue
- 2
- Pages
- 451-480
- ISSN
- 0022-0426 (ISSN-L)
- 1945-1369
- OpenAlex
- W2091136124
- Cited by
- 38
- References
- 11
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research Note — Review of Corrections-Based Therapy for Opiate-Dependent Patients: Implications for Buprenorphine Treatment among Correctional Populations. https://app.cochat.ai/papers/10.1177/002204260403400210
- The paper
- Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2004). Research Note — Review of Corrections-Based Therapy for Opiate-Dependent Patients: Implications for Buprenorphine Treatment among Correctional Populations. Journal of Drug Issues. https://doi.org/10.1177/002204260403400210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.